Keyphrases
Pharmacological Agents
100%
Kidney Disease
100%
Electrolyte Abnormalities
100%
Kidney Cancer
100%
Mineralocorticoid Receptor Antagonists
66%
Hyperkalemia
66%
Immune Checkpoint Inhibitors
66%
Oncology
66%
Electrolyte Disturbances
66%
Hyponatremia
66%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
66%
Immune-related Adverse Events
66%
Water Disturbance
66%
Syndrome of Inappropriate Antidiuresis
66%
High Risk
33%
Pathophysiology
33%
Renin-angiotensin System
33%
Japan
33%
Heart Failure
33%
Hormone Replacement Therapy
33%
Type 1 Diabetes Mellitus (T1DM)
33%
Chronic Kidney Disease
33%
Treatment Outcome
33%
Managing Medication
33%
Diabetic Kidney Disease
33%
Non-immune
33%
Treatment Optimization
33%
Therapeutic Challenges
33%
Electrolyte
33%
Hypomagnesemia
33%
Therapeutic Benefits
33%
Fluid Restriction
33%
Medication-induced
33%
Water Homeostasis
33%
Electrolyte Disorders
33%
Electrolyte Management
33%
Timely Intervention
33%
Hypernatremia
33%
Electrolyte Homeostasis
33%
Hypophysitis
33%
Cardiorenal
33%
Water Management
33%
Young Nephrologists
33%
Medicine and Dentistry
Nephropathy
100%
Disorders of Calcium Metabolism
100%
Kidney Cancer
100%
Oncology
66%
Immune Checkpoint Inhibitor
66%
Hyponatremia
66%
Hyperkalemia
66%
Mineralocorticoid Antagonist
66%
Immune-Related Adverse Events
66%
Antidiuresis
66%
Cotransporter
66%
Medicine
33%
Homeostasis
33%
Hormone Substitution
33%
Pathophysiology
33%
Congestive Heart Failure
33%
Diabetes Mellitus
33%
Chronic Kidney Disease
33%
Nephrologist
33%
Hypomagnesemia
33%
Diabetic Nephropathy
33%
Hypernatremia
33%
Hypophysitis
33%
Treatment Outcome
33%